Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Centogene N.V. (CNTGF : OTC)

• Company Description    Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company?s goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using their knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers. Number of Employees: 493

• Price / Volume Information    Yesterday's Closing Price: $0.15 Daily Weekly Monthly 20 Day Moving Average: 22,200 shares Shares Outstanding: 27.60 (millions) Market Capitalization: $4.22 (millions) Beta: -0.11 52 Week High: $0.40 52 Week Low: $0.06 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 4.15% -0.48% 12 Week -23.45% -34.62% Year To Date 12.91% 5.75%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL AM STRANDE 7 - ROSTOCK,2M 18055 DEU ph: 49-3818-011-3500 fax: - investor.relations@centogene.com http://www.centogene.com

• General Corporate Information    Officers Kim Stratton - Chief Executive Officer Peer M. Schatz - Chairman Miguel Coego Rios - Chief Financial Officer Flemming Ornskov - Member of the Supervisory Board Jonathan G. Sheldon - Member of the Supervisory Board Peer Information Centogene N.V. (HLIS) Centogene N.V. (AZTA) Centogene N.V. (APYI) Centogene N.V. (RNVA) Centogene N.V. (HMSY) Centogene N.V. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: N1976T109 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 27.60 Most Recent Split Date: (:1) Beta: -0.11 Market Capitalization: $4.22 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - - Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©